DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

00719 SHANDONG XINHUA

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Hualu Holdings Group Co. Ltd. (38.10%) Sector Health Care & Biotechnology
Web Site http://www.xhzy.com Tel N/A
Email xhzy@xhzy.com Fax N/A
Related Equities N/A
Principal Activities Mainly engaged in the development, manufacturing, and sales of chemical raw materials, formulations, and chemical products; The main products include “Xinhua Brand” antipyretic and analgesic drugs, cardiovascular and cerebrovascular drugs, antiinfective drugs, and central nervous system drugs.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
华鲁控股集团有限公司 204,864,092(L)  47.99(L)  26/11/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
任福龙 328,296(L)  0.08(L)  28/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top